✦ LIBER ✦

889 EFFICACY AND SAFETY OF PEGYLATED-INTERFERON a-2a PLUS RIBAVIRIN THERAPY IN NAÏVE HCV CIRRHOSIS. PREDICTIVE RESPONSE FACTORS

✍ Scribed by Pascasio, J.M.; Ávila, A.D.; Rojas, N.L.; Sayago, M.; Sousa, J.M.; Ferrer, M.T.; Giráldez, Á.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

[10] THE SAFETY AND EFFICACY OF TARIBAVI

✍ P. Marcellin; Y. Lurie; M. Rodrigues-Torres; R. Chasen; Y. Xu; B. Murphy 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Safety, tolerability, and efficacy of pe

✍ F. TEKIN; F. GUNSAR; Z. KARASU; U. AKARCA; G. ERSOZ 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

751 The safety and efficacy of viramidin

✍ Y. Benhamou; P. Pockros; M. Rodrieuez-Torres; S. Gordon; M. Shiffinan; Y. Lurie; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 117 KB

O.062 The safety and efficacy of Viramid

✍ B. Murphy 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 132 KB

The role of genomic and antigenomic HCV-

✍ J. M. LÓPEZ-ALCOROCHO; E. RODRÍGUEZ-IÑIGO; I. CASTILLO; M. E. CASTELLANOS; M 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 550 KB

275 PREDICTIVE VALUE OF RAPID VIROLOGICA

✍ M. Basso; E.G. Giannini; F. Torre; A. Picciotto 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 55 KB